关注
Andrés Pizzorno
Andrés Pizzorno
Centre International de Recherche en Infectiologie (CIRI) - Team VirPath, Lyon, France
在 univ-lyon1.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Influenza virus resistance to neuraminidase inhibitors
M Samson, A Pizzorno, Y Abed, G Boivin
Antiviral research 98 (2), 174-185, 2013
4092013
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
P Maisonnasse, J Guedj, V Contreras, S Behillil, C Solas, R Marlin, ...
Nature 585 (7826), 584-587, 2020
3862020
Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia
A Pizzorno, B Padey, T Julien, S Trouillet-Assant, A Traversier, ...
Cell Reports Medicine 1 (4), 2020
2442020
Timing of antiviral treatment initiation is critical to reduce SARS‐CoV‐2 viral load
A Gonçalves, J Bertrand, R Ke, E Comets, X De Lamballerie, D Malvy, ...
CPT: pharmacometrics & systems pharmacology 9 (9), 509-514, 2020
2212020
Generation and characterization of recombinant pandemic influenza A (H1N1) viruses resistant to neuraminidase inhibitors
A Pizzorno, X Bouhy, Y Abed, G Boivin
Journal of Infectious Diseases 203 (1), 25-31, 2011
1692011
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2
A Pizzorno, B Padey, J Dubois, T Julien, A Traversier, V Dulière, P Brun, ...
Antiviral research 181, 104878, 2020
1422020
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
J Lopez, M Mommert, W Mouton, A Pizzorno, K Brengel-Pesce, M Mezidi, ...
Journal of Experimental Medicine 218 (10), e20211211, 2021
1292021
Drug repurposing approaches for the treatment of influenza viral infection: reviving old drugs to fight against a long-lived enemy
A Pizzorno, B Padey, O Terrier, M Rosa-Calatrava
Frontiers in immunology 10, 531, 2019
1182019
Influenza drug resistance
A Pizzorno, Y Abed, G Boivin
Seminars in respiratory and critical care medicine 32 (04), 409-422, 2011
1112011
Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses
Y Abed, A Pizzorno, X Bouhy, G Boivin
PLoS pathogens 7 (12), e1002431, 2011
822011
Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus
A Pizzorno, Y Abed, X Bouhy, É Beaulieu, C Mallett, R Russell, G Boivin
Antimicrobial agents and chemotherapy 56 (3), 1208-1214, 2012
772012
Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia
D Asarnow, B Wang, WH Lee, Y Hu, CW Huang, B Faust, PML Ng, ...
Cell 184 (12), 3192-3204. e16, 2021
682021
Impact of Potential Permissive Neuraminidase Mutations on Viral Fitness of the H275Y Oseltamivir-Resistant Influenza A(H1N1)pdm09 Virus In Vitro, in Mice and in …
Y Abed, A Pizzorno, X Bouhy, C Rhéaume, G Boivin
Journal of virology 88 (3), 1652-1658, 2014
592014
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
Q Zhang, A Pizzorno, L Miorin, P Bastard, A Gervais, T Le Voyer, L Bizien, ...
Journal of Experimental Medicine 219 (11), e20220514, 2022
582022
Repurposing of drugs as novel influenza inhibitors from clinical gene expression infection signatures
A Pizzorno, O Terrier, C Nicolas de Lamballerie, T Julien, B Padey, ...
Frontiers in immunology 10, 60, 2019
512019
Antiviral properties of the NSAID drug naproxen targeting the nucleoprotein of SARS-CoV-2 coronavirus
O Terrier, S Dilly, A Pizzorno, D Chalupska, J Humpolickova, E Bouřa, ...
Molecules 26 (9), 2593, 2021
412021
SARS-CoV-2 viral dynamics in non-human primates
A Gonçalves, P Maisonnasse, F Donati, M Albert, S Behillil, V Contreras, ...
PLoS computational biology 17 (3), e1008785, 2021
412021
The 2009 pandemic H1N1 D222G hemagglutinin mutation alters receptor specificity and increases virulence in mice but not in ferrets
Y Abed, A Pizzorno, ME Hamelin, A Leung, P Joubert, C Couture, ...
Journal of Infectious Diseases 204 (7), 1008-1016, 2011
412011
OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes
J Del Campo, A Pizzorno, S Djebali, J Bouley, M Haller, J Pérez-Vargas, ...
NPJ vaccines 4 (1), 4, 2019
402019
Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia
C Nicolas de Lamballerie, A Pizzorno, J Dubois, T Julien, B Padey, ...
Scientific reports 9 (1), 11493, 2019
392019
系统目前无法执行此操作,请稍后再试。
文章 1–20